Clinical trial
Trial of Efficacy and Safety of Pregabalin in Subjects With Neuropathic Pain…
NCT00159705 · Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry · Completed
Key facts
| NCT number | NCT00159705 |
|---|---|
| Title | Trial of Efficacy and Safety of Pregabalin in Subjects With Neuropathic Pain Associated With Lumbo-Sacral Radiculopathy |
| Official title | A Randomized Placebo-Controlled Trial of the Efficacy and Safety of Pregabalin in the Treatment of Subjects With Neuropathic Pain Associated With Lumbo-Sacral Radiculopathy |
| Lead sponsor | Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Radiculopathy |
| Intervention type | Drug |
| Interventions | pregabalin |
| Enrollment | 276 |
| Start date | Apr 1, 2005 |
| Completion | Jun 1, 2007 |
| First posted | Sep 12, 2005 |
| Last update posted | Jan 25, 2021 |
| Countries | Belgium, Canada, Germany, Italy, Spain, Sweden, Turkey (Türkiye), United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: